VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DERM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DERMJourney Medical Corporation
$6.79$187M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDERMQuarterly Financials

Journey Medical Corporation (DERM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Journey Medical Corporation (DERM) quarterly income statement — complete revenue, gross profit & net income history

DERM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue15.96M16.08M17.63M15.01M13.14M13.62M14.63M14.86M13.03M15.26M34.54M17.17M12.21M15.97M16.12M18.29M23.3M17.52M19.61M15.29M
Revenue Growth %21.48%18.05%20.52%1.04%0.84%-10.73%-57.65%-13.49%6.69%-4.44%114.32%-6.12%-47.57%-8.85%-17.82%19.64%117.33%27.65%--
Cost of Goods Sold7.34M6.5M5.75M6M5.86M2.24M5.29M6.54M6.82M6.01M6.43M7.77M6.45M7.72M7.22M7.63M8.2M7.22M8.17M6.28M
COGS % of Revenue46.01%40.46%32.64%40%44.56%16.42%36.13%44.03%52.31%39.42%18.61%45.23%52.8%48.34%44.81%41.73%35.21%41.25%41.65%41.1%
Gross Profit8.62M9.57M11.88M9.01M7.28M11.38M9.34M8.31M6.21M9.24M28.11M9.4M5.76M8.25M8.89M10.66M15.09M10.29M11.44M9M
Gross Margin %53.99%59.54%67.36%60%55.44%83.58%63.87%55.97%47.69%60.58%81.39%54.77%47.2%51.66%55.19%58.27%64.79%58.75%58.35%58.9%
Gross Profit Growth %18.3%-15.89%27.1%8.32%17.22%23.17%-66.76%-11.6%7.81%12.05%216.02%-11.76%-61.81%-19.86%-22.27%18.37%121.6%9%--
Operating Expenses10.11M10.02M13.4M11.88M10.61M9.15M12.24M11.24M16.3M11.35M10.87M17.06M15.32M18.24M18.39M17.8M15.98M19.35M24.09M22.77M
OpEx % of Revenue63.34%62.3%76.03%79.17%80.74%67.17%83.66%75.67%125.13%74.37%31.46%99.34%125.48%114.26%114.09%97.32%68.6%110.46%122.84%148.92%
Selling, General & Admin10.11M9.86M011.88M10.57M10.06M11.4M10.33M8.42M9.84M8.64M12.14M13.29M13.99M15.57M15.19M14.71M000
SG&A % of Revenue63.34%61.34%-79.17%80.44%73.86%77.9%69.53%64.62%64.5%25%70.7%108.83%87.6%96.64%83.05%63.17%---
Research & Development0154K287K039K218K842K913K7.88M1.5M2.23M1.77M2.03M4.26M2.81M2.61M1.27M1.99M794K13.77M
R&D % of Revenue-0.96%1.63%-0.3%1.6%5.76%6.15%60.51%9.86%6.45%10.33%16.65%26.66%17.45%14.26%5.43%11.37%4.05%90.08%
Other Operating Expenses001000K00-1000K000001000K000001000K1000K1000K
Operating Income-1.49M-443K-1.53M-2.88M-3.32M2.23M-2.89M-2.93M-10.09M-2.1M17.25M-7.65M-9.56M-9.99M-9.49M-7.14M-888K-9.06M-12.65M-13.76M
Operating Margin %-9.35%-2.76%-8.67%-19.16%-25.3%16.4%-19.78%-19.7%-77.44%-13.79%49.93%-44.57%-78.29%-62.6%-58.9%-39.05%-3.81%-51.7%-64.49%-90.02%
Operating Income Growth %55.11%-119.83%47.17%1.74%67.06%206.18%-116.78%61.75%-5.53%78.95%281.68%-7.15%-976.69%-10.36%24.94%48.11%-251.79%-349.78%--
EBITDA-343K645K-465K-1.79M-2.24M3.24M-2.06M-2.09M-9.25M-1.27M18.08M-6.56M-8.47M-8.75M-8.45M-6.1M151K-8.57M-11.99M-13.02M
EBITDA Margin %-2.15%4.01%-2.64%-11.93%-17.03%23.77%-14.06%-14.06%-71.02%-8.3%52.35%-38.22%-69.35%-54.79%-52.45%-33.37%0.65%-48.9%-61.13%-85.18%
EBITDA Growth %84.67%-80.07%77.39%14.27%75.82%355.69%-111.38%68.19%-9.26%85.53%313.9%-7.54%-5709.27%-2.11%29.49%53.13%-87.08%-315.12%--
D&A (Non-Cash Add-back)1.15M1.09M1.06M1.09M1.09M1M837K839K836K838K836K1.09M1.09M1.25M1.04M1.04M1.04M491K658K741K
EBIT-1.49M-443K-1.38M-2.88M-3.32M2.41M-1.63M-2.8M-9.89M-1.99M17.15M-7.61M-9.49M-10.01M-9.51M-7.14M-885K-6.76M-106K-12.56M
Net Interest Income-735K-785K-783K-799K-742K-640K-570K-402K-331K89K-260K-677K-528K-567K-556K-450K-386K-4.1M-1.37M-1.34M
Interest Income157K148K154K138K149K191K188K161K217K113K8K79K122K50K3K4K3K000
Interest Expense892K933K937K937K891K831K758K563K548K24K268K756K650K617K559K454K389K4.1M1.37M1.34M
Other Income/Expense-738K-804K-786K-860K-749K-652K504K-434K-352K87K-361K-710K-575K-634K-578K-450K-386K-4.36M-1.38M-1.52M
Pretax Income-2.23M-1.25M-2.31M-3.74M-4.07M1.58M-2.39M-3.36M-10.44M-2.02M16.88M-8.36M-10.14M-10.63M-10.07M-7.59M-1.27M-13.42M-14.02M-15.29M
Pretax Margin %-13.97%-7.76%-13.13%-24.89%-31%11.62%-16.34%-22.63%-80.14%-13.22%48.88%-48.7%-82.99%-66.57%-62.48%-41.51%-5.47%-76.59%-71.5%-99.99%
Income Tax00060K061K000126K95K0013K10K-64K104K8.34M-3.38M-3.42M
Effective Tax Rate %0%0%0%-1.61%0%3.86%0%0%0%-6.25%0.56%0%0%-0.12%-0.1%0.84%-8.16%-62.13%24.07%22.39%
Net Income-2.23M-1.25M-2.31M-3.8M-4.07M1.52M-2.39M-3.36M-10.44M-2.14M16.79M-8.36M-10.14M-10.64M-10.08M-7.53M-1.38M-21.75M-10.65M-11.87M
Net Margin %-13.97%-7.76%-13.13%-25.29%-31%11.17%-16.34%-22.63%-80.14%-14.05%48.61%-48.7%-82.99%-66.65%-62.55%-41.16%-5.92%-124.17%-54.29%-77.61%
Net Income Growth %45.25%-181.99%3.14%-12.94%60.99%170.98%-114.24%59.81%-3.02%79.86%266.56%-11.09%-635.56%51.07%5.32%36.55%-614.18%-969.34%--
Net Income (Continuing)-2.23M-1.25M-2.31M-3.8M-4.07M1.52M-2.39M-3.36M-10.44M-2.14M16.79M-8.36M-10.14M-10.64M-10.08M-7.53M-1.38M-21.75M-10.65M-11.87M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.05-0.09-0.16-0.180.07-0.12-0.17-0.53-0.110.80-0.46-0.56-0.60-0.57-0.43-0.08-1.64-1.16-1.30
EPS Growth %55.56%-166.81%25%5.88%66.04%162.45%-115%63.04%5.36%81.67%240.35%-6.98%-603.52%63.41%50.86%66.92%-371.67%-1193.33%--
EPS (Basic)-0.08-0.05-0.09-0.16-0.180.07-0.12-0.17-0.53-0.110.91-0.46-0.56-0.60-0.57-0.43-0.08-1.64-1.16-1.30
Diluted Shares Outstanding27.31M24.5M24.96M23.29M22.61M22.15M20.54M19.99M19.76M19.32M21.03M18.01M17.81M17.73M17.62M17.46M17.32M13.24M9.16M9.16M
Basic Shares Outstanding27.31M24.5M24.96M23.29M22.61M22.15M20.54M19.99M19.76M19.32M18.42M18.01M17.81M17.73M17.62M17.46M17.32M13.23M9.16M9.13M
Dividend Payout Ratio--------------------